Northern Trust Corp boosted its position in Delek US Holdings, Inc. (NYSE:DK - Free Report) by 9.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 987,086 shares of the oil and gas company's stock after buying an additional 83,246 shares during the period. Northern Trust Corp owned approximately 1.63% of Delek US worth $14,875,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also bought and sold shares of DK. Price T Rowe Associates Inc. MD lifted its holdings in Delek US by 21.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 54,042 shares of the oil and gas company's stock valued at $1,000,000 after buying an additional 9,600 shares during the period. Mercer Global Advisors Inc. ADV bought a new position in shares of Delek US during the 4th quarter worth about $532,000. Ameriprise Financial Inc. boosted its position in shares of Delek US by 14.4% during the 4th quarter. Ameriprise Financial Inc. now owns 792,111 shares of the oil and gas company's stock worth $14,654,000 after purchasing an additional 99,521 shares in the last quarter. Bayesian Capital Management LP bought a new position in shares of Delek US during the 4th quarter worth about $390,000. Finally, Brevan Howard Capital Management LP boosted its position in shares of Delek US by 266.3% during the 4th quarter. Brevan Howard Capital Management LP now owns 37,138 shares of the oil and gas company's stock worth $687,000 after purchasing an additional 26,998 shares in the last quarter. Institutional investors and hedge funds own 97.01% of the company's stock.
Delek US Trading Up 3.1%
DK opened at $31.95 on Thursday. The company has a debt-to-equity ratio of 10.48, a current ratio of 0.80 and a quick ratio of 0.50. Delek US Holdings, Inc. has a fifty-two week low of $11.02 and a fifty-two week high of $32.38. The firm has a market capitalization of $1.92 billion, a PE ratio of -2.60 and a beta of 1.09. The company's 50-day moving average is $23.81 and its 200 day moving average is $18.91.
Delek US (NYSE:DK - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The oil and gas company reported ($0.56) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.92) by $0.36. The business had revenue of $2.76 billion during the quarter, compared to the consensus estimate of $2.68 billion. Delek US had a negative net margin of 7.11% and a negative return on equity of 79.27%. The firm's quarterly revenue was down 16.4% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.92) EPS. As a group, research analysts predict that Delek US Holdings, Inc. will post -5.5 earnings per share for the current fiscal year.
Delek US Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, August 18th. Shareholders of record on Monday, August 11th were paid a $0.255 dividend. The ex-dividend date was Monday, August 11th. This represents a $1.02 annualized dividend and a yield of 3.2%. Delek US's dividend payout ratio (DPR) is -8.30%.
Analyst Upgrades and Downgrades
A number of equities analysts have recently issued reports on DK shares. Wells Fargo & Company increased their price objective on shares of Delek US from $11.00 to $15.00 and gave the stock an "underweight" rating in a research report on Wednesday, June 11th. Cowen reissued a "sell" rating on shares of Delek US in a research report on Friday, August 8th. Scotiabank reissued a "sector perform" rating and set a $20.00 price objective (up previously from $14.00) on shares of Delek US in a research report on Friday, July 11th. The Goldman Sachs Group increased their price objective on shares of Delek US from $15.00 to $17.00 and gave the stock a "neutral" rating in a research report on Friday, May 23rd. Finally, Morgan Stanley increased their price objective on shares of Delek US from $15.00 to $19.00 and gave the stock an "underweight" rating in a research report on Wednesday, July 16th. Three investment analysts have rated the stock with a Buy rating, six have given a Hold rating and five have assigned a Sell rating to the stock. According to MarketBeat, Delek US currently has a consensus rating of "Reduce" and a consensus target price of $23.77.
View Our Latest Report on DK
Delek US Company Profile
(
Free Report)
Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.
Read More
Want to see what other hedge funds are holding DK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Delek US Holdings, Inc. (NYSE:DK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Delek US, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delek US wasn't on the list.
While Delek US currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.